RandolphSMarksMD

Oncology • Rochester, MN

Assistant Professor, Oncology, Mayo Medical School

Join to view full profile

Dr. Marks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Marks' full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1989 - 1993
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1986 - 1989
University of California, Irvine, School of MedicineClass of 1986

Certifications & Licensure

MN State Medical License 1987 - 2025
American Board of Internal Medicine Internal Medicine

Clinical Trials

Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions Start of enrollment: 1997 Jan 10
Completed
Phase 3
Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas Start of enrollment: 1991 Oct 01
Completed
Phase 2
Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 1998 Apr 01
Completed
Phase 3
S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer Start of enrollment: 1999 Oct 01
Completed
Phase 3
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Start of enrollment: 2000 Dec 18
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

56 citations
Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA.
Liang Wang, Jeremiah A. Aakre, Ruoxiang Jiang, Randolph S. Marks, Yanhong Wu
Journal of Thoracic Oncology. 2010-06-01
213 citations
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
Scott M. Lippman, J. Jack Lee, Daniel D. Karp, Everett E. Vokes, Steven E. Benner
Journal of the National Cancer Institute. 2001-04-18
176 citations
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study
Yafei Li, Chau-Chyun Sheu, Yuanqing Ye, Mariza de Andrade, Liang Wang
The Lancet. Oncology. 2010-04-01